Inozyme Pharma, Inc. Separation Agreements
2 Contracts & Agreements
- Executive Transition, Separation, and Release of Claims Agreement, dated December 7, 2022 by and between Inozyme Pharma, Inc. and Henric Bjarke (Filed With SEC on December 8, 2022)
- Separation Agreement, dated November 3, 2021, by and between the Registrant and Deborah Wenkert (Filed With SEC on March 15, 2022)
